Loading clinical trials...

Reducing Involuntary Movements in Participants With Tardive Dyskinesia | Clinical Trials | Clareo Health

COMPLETEDPhase 3NCT02198794

Reducing Involuntary Movements in Participants With Tardive Dyskinesia

The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of SD-809 in reducing the severity of abnormal involuntary movements of moderate to severe tardive dyskinesia....

Lead sponsor: Auspex Pharmaceuticals, Inc.•44 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia

NCT07365462 · Tardive Dyskinesia

RECRUITINGNA

Single-Center, Double-Blind, Randomized, Placebo-Controlled Study on Efficacy and Safety of rTMS (With Precise Localization) in Relieving Motor Symptoms of TD

NCT07173920 · Tardive Dyskinesia, Repetitive Transcranial Magnetic Stimulation

Not Yet RecruitingPhase 4

Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities

NCT06997198 · Tardive Dyskinesia, Intellectual Disability, and more

COMPLETEDPhase 4

Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia

NCT05859698 · Schizophrenia, Schizoaffective Disorder, and more

COMPLETEDPhase 1

Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets

NCT06474650 · Huntington Disease, Tardive Dyskinesia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 1, 2022Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment343

Start dateOct 2014

Last updatedApr 1, 2022

Condition

Tardive Dyskinesia

Locations shown

Teva Investigational Site 145

Tuscaloosa, Alabama

Teva Investigational Site 107

Anaheim, California

Teva Investigational Site 108

Anaheim, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 1, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions